UBP-302

From Wikipedia, the free encyclopedia
Jump to: navigation, search
UBP-302
UBP-302.png
Names
IUPAC name
2-{[3-[(2S)-2-amino-2-carboxyethyl]-2,6-dioxo-3,6-dihydropyrimidin-1(2H)-yl]methyl}benzoic acid
Identifiers
745055-91-8 YesY
Jmol-3D images Image
Properties
C15H15N3O6
Molar mass 333.296 g/mol
Except where noted otherwise, data is given for materials in their standard state (at 25 °C (77 °F), 100 kPa)
 YesY verify (what isYesY/N?)
Infobox references

UBP-302 is a highly selective kainate receptor antagonist used in the study of many neurological processes. It is active at micromolar concentration within an in vitro preparation and specifically targets the GluR5 subunit of the receptor. This compound was developed at the University of Bristol.[1]

References[edit]

  1. ^ More, JC; Nistico, R; Dolman, NP; Clarke, VR; Alt, AJ; Ogden, AM; Buelens, FP; Troop, HM et al. (2004). "Characterisation of UBP296: a novel, potent and selective kainate receptor antagonist". Neuropharmacology 47 (1): 46–64. doi:10.1016/j.neuropharm.2004.03.005. PMID 15165833.